Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
biote Corp. BTMD
$5.73
+$0.23 (3.99%)
На 18:05, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
442416621.00000000
-
week52high
10.53
-
week52low
2.00
-
Revenue
164957000
-
P/E TTM
1
-
Beta
0.59120100
-
EPS
-0.12000000
-
Last Dividend
0.00000000
-
Next Earnings Date
09 мая 2023 г. в 04:00
Описание компании
biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biote-branded dietary supplements; and sterile pellet insertion kits for men and women. The company was founded in 2011 and is headquartered in Irvine, Texas.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Cowen & Co. | Outperform | 24 июн 2022 г. | |
| Roth Capital | Buy | 23 июн 2022 г. | |
| Truist Securities | Buy | 27 сент 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| MORRIS DEBRA L | A | 30000 | 30000 | 09 янв 2023 г. |
| Kamdar Samar Jagat | A | 13000 | 13000 | 09 янв 2023 г. |
| Cone Stephen Mark | A | 106823 | 83350 | 09 янв 2023 г. |
| HEYER ANDREW R | A | 345201 | 100000 | 09 янв 2023 г. |
| HEYER ANDREW R | A | 1473513 | 100000 | 09 янв 2023 г. |
| Weber Teresa Sue | D | 85040 | 865384 | 09 янв 2023 г. |
| Beer Marc D | D | 0 | 865384 | 09 янв 2023 г. |
| Weber Teresa Sue | D | 2967092 | 865384 | 06 янв 2023 г. |
| Weber Teresa Sue | D | 2967092 | 865384 | 06 янв 2023 г. |
| Weber Teresa Sue | A | 950424 | 865384 | 06 янв 2023 г. |
Новостная лента
Biote Schedules Third Quarter 2022 Financial Results Release and Conference Call
Business Wire
31 окт 2022 г. в 08:30
IRVING, Texas--(BUSINESS WIRE)--biote Corp. (Nasdaq: BTMD) (“Biote” or the “Company”), a leading provider of preventive health care through the delivery of personalized hormone therapy, today announced the Company will provide third quarter financial results on Tuesday, November 8, 2022, after the close of the market.
Biote to Report Second Quarter 2022 Financial Results on August 9, 2022 and Host Conference Call on August 10, 2022
Business Wire
20 июл 2022 г. в 11:00
IRVING, Texas--(BUSINESS WIRE)--biote Corp. (“Biote” or the “Company”) (Nasdaq: BTMD), a high growth, medical practice-building business within the hormone optimization space, will report its financial results for the second quarter ended June 30, 2022, after market close on Tuesday, August 9, 2022. Terry Weber, Chief Executive Officer, and the Company's management will host a conference call to review these results and provide a business update beginning at 8:30 a.m. ET on Wednesday, August 10